BNP Paribas Financial Markets lowered its holdings in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 68.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,078 shares of the scientific and technical instruments company's stock after selling 15,583 shares during the period. BNP Paribas Financial Markets owned approximately 0.08% of Transcat worth $748,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Ameriprise Financial Inc. raised its holdings in Transcat by 2.6% during the 4th quarter. Ameriprise Financial Inc. now owns 70,997 shares of the scientific and technical instruments company's stock valued at $7,507,000 after acquiring an additional 1,804 shares during the period. Comerica Bank grew its position in shares of Transcat by 5.9% in the fourth quarter. Comerica Bank now owns 64,600 shares of the scientific and technical instruments company's stock valued at $6,831,000 after purchasing an additional 3,594 shares in the last quarter. Northern Trust Corp raised its stake in shares of Transcat by 6.7% during the 4th quarter. Northern Trust Corp now owns 114,755 shares of the scientific and technical instruments company's stock valued at $12,134,000 after purchasing an additional 7,171 shares during the period. Aquatic Capital Management LLC raised its stake in shares of Transcat by 1,052.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock valued at $122,000 after purchasing an additional 1,052 shares during the period. Finally, Nebula Research & Development LLC raised its stake in shares of Transcat by 31.6% during the 4th quarter. Nebula Research & Development LLC now owns 7,103 shares of the scientific and technical instruments company's stock valued at $751,000 after purchasing an additional 1,707 shares during the period. 98.34% of the stock is currently owned by hedge funds and other institutional investors.
Transcat Stock Up 1.4%
TRNS stock opened at $91.63 on Friday. The company's 50 day moving average is $79.06 and its 200 day moving average is $89.79. The stock has a market cap of $852.98 million, a price-to-earnings ratio of 49.53 and a beta of 0.69. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. Transcat, Inc. has a 1-year low of $67.56 and a 1-year high of $147.12.
Transcat (NASDAQ:TRNS - Get Free Report) last issued its quarterly earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). Transcat had a return on equity of 7.23% and a net margin of 6.22%. The company had revenue of $77.13 million during the quarter, compared to the consensus estimate of $76.40 million. Transcat's revenue for the quarter was up 8.8% on a year-over-year basis. Sell-side analysts predict that Transcat, Inc. will post 2.3 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on TRNS. Oppenheimer downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 29th. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a research note on Tuesday. HC Wainwright raised their price target on shares of Transcat from $106.00 to $116.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Northland Securities restated a "market perform" rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, Transcat has an average rating of "Hold" and an average target price of $114.00.
Get Our Latest Stock Report on TRNS
About Transcat
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Read More
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
